NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 50 min 11 sec ago

Large scale mapping and/or molecular profiling of ensembles and/or cell-types mediating opioid action in the rodent brain (R01 - Clinical Trial Not Allowed)

Wed, 2020-06-24 03:58
Funding Opportunity PAR-20-241 from the NIH Guide for Grants and Contracts. This funding opportunity announcement aims to support research that employs innovative scalable technologies to inventory, register and profile the cellular ensembles and/or cell-types that produce and/or respond to opioids. Emphasis is on approaches that enable high-throughput single-cell resolution mapping, anatomical characterization and/or molecular profiling of cells identified as primary sources of, or pharmacological targets of, opioids in the brain and/or whose changes in activity associate with opioid-related behaviors in rodents.

Notice to Extend, "PAR-17-264 " Innovative Mental Health Services Research Not Involving Clinical Trials (R01)

Tue, 2020-06-23 13:59
Notice NOT-MH-20-063 from the NIH Guide for Grants and Contracts

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Tue, 2020-06-23 12:51
Funding Opportunity PA-20-242 from the NIH Guide for Grants and Contracts. The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Notice of Intent to Publish a Funding Opportunity Announcement for Glioblastoma Therapeutics Network (U19 Clinical Trial Required)

Tue, 2020-06-23 12:04
Notice NOT-CA-20-073 from the NIH Guide for Grants and Contracts

Upcoming Mandatory Submission of the Federal Financial Report (FFR) in the Payment Management System Beginning January 1, 2021

Tue, 2020-06-23 11:42
Notice NOT-OD-20-127 from the NIH Guide for Grants and Contracts

Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project (U24 Clinical Trial Not Allowed)

Tue, 2020-06-23 03:42
Funding Opportunity RFA-HD-21-008 from the NIH Guide for Grants and Contracts. The NIH is coordinating efforts for establishing a developmental Genotype-Tissue Expression (dGTEx) project, to catalog and analyze transcriptional profiles from a wide variety of tissues obtained from neonates, children, and adolescents in a post-mortem setting. The purpose of this funding opportunity is for support of a Biospecimen Procurement Center (BPC) to enroll suitable pediatric donors and provide high quality tissue samples for analyses to the Laboratory, Data Analysis, and Coordinating Center (LDACC). The BPC will work closely with the LDACC to optimize tissue collection, preservation and transfer of specimens.

Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project(U24) (Clinical Trial Not Allowed)

Fri, 2020-06-19 12:37
Funding Opportunity RFA-HG-20-039 from the NIH Guide for Grants and Contracts. The National Human Genome Research Institute (NHGRI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development are coordinating efforts for establishing a Developmental Genotype-Tissue Expression (dGTEx) project, to catalog and analyze transcriptional profiles from a wide variety of tissues obtained from neonates, children, and adolescents in a post-mortem setting. The purpose of this FOA is to solicit applications to develop and implement a Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression (dGTEx) Project. The LDACC will perform 2 major functions: a molecular laboratory, and a data analysis and coordinating center. As a molecular laboratory, the LDACC will work with the Biospecimen Procurement Center (BPC) funded by NICHD to process tissue samples for sequencing and biobanking. Responsibilities as a data analysis and coordinating center include ensuring close coordination with the BPC, monitoring study progress and laboratory performance, performing basic analysis of data for gene expression analyses, and harmonizing and submitting datasets to be deposited in repositories such as the AnVIL ((Analysis, Visualization, and Informatics Lab-space) https://anvilproject.org/) or the GTEx portal (https://gtexportal.org/home/).

NIAID Late Application Policy for NIAID-Specific FOAs with Due Dates in July and August 2020

Fri, 2020-06-19 12:15
Notice NOT-AI-20-054 from the NIH Guide for Grants and Contracts

Notice of Pre-Application Webinar for the RADx-UP Initiative

Fri, 2020-06-19 03:03
Notice NOT-OD-20-131 from the NIH Guide for Grants and Contracts

NIH Summary Statement Available to the Signing Officials (SO) through the eRA Commons

Thu, 2020-06-18 11:47
Notice NOT-OD-20-126 from the NIH Guide for Grants and Contracts

Notice of Special Interest (NOSI): Common Fund ALS-related Transformative Research Award (R01 Clinical Trial Optional)

Wed, 2020-06-17 12:03
Notice NOT-RM-20-019 from the NIH Guide for Grants and Contracts

Regional Medical Libraries for the Network of the National Library of Medicine (UG4)

Wed, 2020-06-17 11:15
Funding Opportunity RFA-LM-20-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites cooperative agreement (UG4) applications for Regional Medical Libraries (RMLs) as the central component of the Network of the National Library of Medicine (NNLM). The NNLM consists of 7 regional medical libraries and thousands of member organizations located throughout the US. The mission of the NNLM is to provide U.S. researchers, health professionals, public health workforce, educators, and the public with equal access to biomedical and health information resources and data. The RMLs carry out regional and national programs in support of the mission. This includes training, funding, and engagement opportunities for member libraries and other organizations to carry out regional and national programs. Regionally, RMLs assess and interpret the needs of current and potential audiences to expand the reach and impact of the National Library of Medicine (NLM). As a group, the RMLs ensure continuity for essential programs of the NNLM, and cooperatively design, implement, and evaluate innovative approaches to serving the biomedical and health information needs of researchers, health professionals, public health workforce, educators, and the public in communities across the U.S., including persons who experience health disparities and populations underrepresented in biomedical research.

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

Wed, 2020-06-17 04:31
Funding Opportunity PAR-20-237 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.

Pages